MMP13 antibody (Cleaved-Tyr104)
Quick Overview for MMP13 antibody (Cleaved-Tyr104) (ABIN8122795)
Target
See all MMP13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Cleaved-Tyr104
-
Purpose
- MMP13 (Cleaved-Tyr104) Antibody
-
Specificity
- This antibody detects endogenous levels of Human MMP13 (Cleaved-Tyr104, protein was cleaved amino acid sequence between 103-104 )
-
Purification
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
-
Immunogen
- Synthesized peptide derived from human MMP13 (Cleaved-Tyr104)
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-2000,IHC 1:50-300, ELISA 2000-20000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C/1 year
-
Expiry Date
- 12 months
-
-
- MMP13 (Matrix Metallopeptidase 13 (Collagenase 3) (MMP13))
-
Alternative Name
- MMP13
-
Background
-
Synonyms: Collagenase 3 (EC 3.4.24.-, Matrix metalloproteinase-13, MMP-13)
Background: cofactor:Binds 2 zinc ions per subunit.,cofactor:Binds 4 calcium ions per subunit.,disease:Defects in MMP13 are the cause of spondyloepimetaphyseal dysplasia type 2 (SEMD2) [MIM:602111], also known as spondyloepimetaphyseal dysplasia type Missouri. SEMDs are a heterogeneous group of skeletal disorders characterized by defective growth and modeling of the spine and long bones. The SEMDs are distinguished from the spondylometaphyseal dysplasias and the spondyloepiphyseal dysplasias by the combined involvement of the epiphyses and metaphyses. The 3 disorders have malformations of the vertebrae in common.,domain:The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.,function:Degrades collagen type I. Does not act on gelatin or casein. Could have a role in tumoral process.,similarity:Belongs to the peptidase M10A family.,similarity:Contains 4 hemopexin-like domains.,tissue specificity:Seems to be specific to breast carcinomas.,
Gene Name: MMP13
Protein Name: MMP13 (Cleaved-Tyr104)
-
Gene ID
- 4322
-
UniProt
- P45452
Target
-